A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres.
cost overview
laparoscopy
rectal cancer
rectal surgery
robotic
robotic surgery
transanal total mesorectal excision
Journal
Annals of surgery open : perspectives of surgical history, education, and clinical approaches
ISSN: 2691-3593
Titre abrégé: Ann Surg Open
Pays: United States
ID NLM: 101769928
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
05
01
2023
accepted:
16
01
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview. This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis. In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively ( Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach.
Sections du résumé
Background
UNASSIGNED
Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview.
Method
UNASSIGNED
This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis.
Results
UNASSIGNED
In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively (
Conclusion
UNASSIGNED
Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach.
Identifiants
pubmed: 37600875
doi: 10.1097/AS9.0000000000000263
pmc: PMC10431334
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e263Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Ann Surg. 2018 Feb;267(2):243-251
pubmed: 28549014
Tech Coloproctol. 2022 Feb;26(2):99-108
pubmed: 34837140
Medicine (Baltimore). 2015 Jun;94(22):e823
pubmed: 26039115
Int J Colorectal Dis. 2017 Oct;32(10):1423-1429
pubmed: 28791457
J Am Coll Surg. 2013 Dec;217(6):1063-9.e1
pubmed: 24041555
Updates Surg. 2021 Feb;73(1):85-91
pubmed: 32929690
Surg Endosc. 2014 Jan;28(1):212-21
pubmed: 23996335
Eur J Surg Oncol. 2013 Oct;39(10):1063-70
pubmed: 23871573
Eur J Surg Oncol. 2020 Sep;46(9):1668-1672
pubmed: 32061459
Int J Colorectal Dis. 2022 Sep;37(9):1975-1982
pubmed: 35943579
Dis Colon Rectum. 2003 Dec;46(12):1633-9
pubmed: 14668588
Br J Surg. 2012 Sep;99(9):1219-26
pubmed: 22864881
Dis Colon Rectum. 2019 Jun;62(6):747-754
pubmed: 31094961
J Am Coll Surg. 2019 Mar;228(3):235-244.e1
pubmed: 30639298
JAMA. 2017 Oct 24;318(16):1569-1580
pubmed: 29067426
BMJ Open. 2022 Aug 19;12(8):e057640
pubmed: 35985776
Br J Surg. 2021 Nov 11;108(11):1380-1387
pubmed: 34370834
Ann Surg. 2015 Feb;261(2):221-7
pubmed: 25185463
Dis Colon Rectum. 2012 Dec;55(12):1300-10
pubmed: 23135590
Surg Endosc. 2018 May;32(5):2312-2321
pubmed: 29098433
Surgery. 2021 Jul;170(1):345-346
pubmed: 33781586
Int J Surg. 2012;10(6):305-9
pubmed: 22561738
J Cancer. 2012;3:49-57
pubmed: 22315650
Colorectal Dis. 2021 May;23(5):1071-1082
pubmed: 33539646
J Clin Oncol. 2007 Jul 20;25(21):3061-8
pubmed: 17634484
Ann Med. 1997 Apr;29(2):127-33
pubmed: 9187227
Tech Coloproctol. 2018 Apr;22(4):279-287
pubmed: 29569099
Dis Colon Rectum. 2013 Apr;56(4):408-15
pubmed: 23478607
J Laparoendosc Adv Surg Tech A. 2018 Feb;28(2):189-200
pubmed: 29232537
Int J Colorectal Dis. 2016 Apr;31(4):805-11
pubmed: 26847617
Int J Colorectal Dis. 2016 Dec;31(12):1807-1815
pubmed: 27714517
Surg Endosc. 2022 Sep;36(9):6337-6360
pubmed: 35697853
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Ann Med Surg (Lond). 2019 Jul 07;45:36-39
pubmed: 31360458
Surg Endosc. 2005 Jan;19(1):117-9
pubmed: 15549629
JSLS. 2014 Oct-Dec;18(4):
pubmed: 25489216
Health Policy Plan. 2000 Jun;15(2):230-4
pubmed: 10837047
Surg Endosc. 2020 Apr;34(4):1534-1542
pubmed: 29998391